LAUREN GILKEY: Open Payments
NPI 1295284156 · FAYETTEVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 31 payments from 15 companies in 2025. Trend: 2023 $1,255 · 2024 $746 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $149 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| Novo Nordisk Inc | 3 | $53 |
| PFIZER INC. | 3 | $44 |
| Lundbeck LLC | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
Products named: CREON, TRELEGY ELLIPTA, QULIPTA, Ozempic, REXULTI, AIRSUPRA, UBRELVY, PREVNAR 20.
Industry payments across NY — which companies pay providers there.
